Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroups
This study provides valuable insights into the occurrence of ADEs following tirzepatide administration, potentially supporting clinical monitoring and risk identification efforts.
Authors
- Zhiwei Cui (ORCID: https://orcid.org/0000-0001-8338-4270)
- Ruizhen Zhao
- Junyou Chen
- Fan Zou (ORCID: https://orcid.org/0000-0002-4436-6923)
- Li Wang (ORCID: https://orcid.org/0000-0001-9639-1058)
- Liyuan Zhou (ORCID: https://orcid.org/0000-0001-7485-8163)
- Siyu Lou
- Yingyong Ou
- Chengyu Zhu (ORCID: https://orcid.org/0000-0002-2885-7394)
Institutions
- Zunyi Medical University (CN)
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.3389/fphar.2024.1463657
- Citations
- 16
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 5.61
Funders
- Health Commission of Guizhou Province